Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling-Reference-Cited by-同舟云学术

Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling

Published:2013-12-13 Issue:3 Volume:74 Page:921-931
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Pishas Kathleen I.,Neuhaus Susan J.,Clayer Mark T.,Schreiber Andreas W.,Lawrence David M.,Perugini Michelle,Whitfield Robert J.,Farshid Gelareh,Manavis Jim,Chryssidis Steve,Mayo Bronwen J.,Haycox Rebecca C.,Ho Kristen,Brown Michael P.,D'Andrea Richard J.,Evdokiou Andreas,Thomas David M.,Desai Jayesh,Callen David F.,Neilsen Paul M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAM193A is a positive regulator of p53 activity;Cell Reports;2023-03

2. Silver In Situ Hybridization for the Rapid Assessment of MDM2 Amplification in Soft Tissue and Bone Tumors. Validation Based on an Audit of 192 Consecutive Cases Evaluated by Silver In Situ Hybridization and Fluorescence In Situ Hybridization;Applied Immunohistochemistry & Molecular Morphology;2023-01-25

3. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review;Seminars in Cancer Biology;2022-11

4. Simultaneous regression and classification for drug sensitivity prediction using an advanced random forest method;Scientific Reports;2022-08-05

5. Identification of ZER6 Isoform p52-ZER6 as an Antitumour Therapeutic Response Determinant for MDM2-p53 Binding Inhibitors;SSRN Electronic Journal;2022